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https://doi.org/10.1016/j.stemcr.2018.02.004SUMMARYYin Yang 1 (YY1) regulates early embryogenesis and adult tissue formation. However, the role of YY1 in stem cell regulation remains un-
clear. YY1 has a Polycomb group (PcG) protein-dependent role in mammalian cells. The PcG-independent functions of YY1 are also
reported, although their underlyingmechanism is still undefined. This paper reports the role of YY1 and BAF complex in theOCT4-medi-
ated pluripotency network inmouse embryonic stem cells (mESCs). The interaction between YY1 and BAF complex promotesmESC pro-
liferation and pluripotency. Knockdown of Yy1 or Smarca4, the core component of the BAF complex, downregulates pluripotency
markers and upregulates several differentiation markers. Moreover, YY1 enriches at both promoter and super-enhancer regions to stim-
ulate transcription. Thus, this study elucidates the role of YY1 in regulating pluripotency through its interaction with OCT4 and the BAF
complex and the role of BAF complex in integrating YY1 into the core pluripotency network.INTRODUCTION
Yin Yang 1 (YY1) is the mammalian ortholog of pleioho-
meotic, a transcription factor that binds Polycomb DNA
response elements in Drosophila melanogaster and recruits
Polycomb group (PcG) proteins to DNA (Brown et al.,
1998). Like certain DNA sequences (Farcas et al., 2012;
Wu et al., 2013), transcription factors (Endoh et al.,
2008), pre-existing histone modifications (Bernstein
et al., 2006), and non-coding RNA (Kotake et al., 2011),
YY1 is also considered as one of the well-accepted DNA
binding factors that can recruit PcG proteins to specific
chromatin sites (Bracken and Helin, 2009). YY1 was origi-
nally identified as a transcriptional repressor due to its
interactionwith the Polycomb repressive complex 2 (Satijn
et al., 2001), which further initiates the tri-methylation of
K27 of histone 3 (H3K27me3) to repress specific genes,
such as MHCIIb and MCK, during myoblast differentiation
(Caretti et al., 2004). Moreover, YY1 has been reported to
regulate cell proliferation and differentiation (Gordon1324 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018 j ª 2018 The
This is an open access article under the CC BY-NC-ND license (http://creativet al., 2006), and its deficiency in mice caused peri-implan-
tation lethality during embryonic development (Donohoe
et al., 1999). Within the B lineage of lymphocytes, YY1 has
played critical roles at all stages of B cell differentiation
(Kleiman et al., 2016). Conditional deletion of Yy1 resulted
in a blockage at the pro-B cell to pre-B cell stage (Liu et al.,
2007).
Several studies also pointed out that YY1 has transcrip-
tional activation functions independent of PcG. Findings
by Lee et al. (1995) demonstrated that the association of
YY1 with p300 resulted in histone acetylation, which
caused gene activation by facilitating the binding of RNA
polymerase and transcription factors to promoter regions.
Studies by the Seto team revealed that YY1 recruited
PRMT1 to mediate histone methylation on lysine and argi-
nine residues, and this PRMT1-mediated histone H4-R3
methylation also induced transcriptional activation (Re-
zai-Zadeh et al., 2003). In addition, the association of YY1
withMDM2, PIASy, andUBC9 contributed to protein ubiq-
uitination and sumoylation (Deng et al., 2007; Sui et al.,Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
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2004). Furthermore, Lu et al. (2013) found no significant
co-occupancy between YY1 and Ezh2. They provided evi-
dence that YY1 acts as an activator for many loci, suggest-
ing an Ezh2-independent role of YY1 inmuscle cells.Works
by the Young group proposed a model wherein YY1 binds
to both gene-regulatory elements and their associated
RNAs, which further enhances YY1 occupancy at these
elements (Sigova et al., 2015). This finding outlined a pos-
itive feedback loop that contributed to the stability of gene
expression programs regulated by YY1. YY1 also plays a
potential role in different cancer types. It was reported
that ectopic expression of YY1 results in carcinogenesis
through cell-cycle deregulation (Gordon et al., 2006). The
dynamic interactions between YY1 and the cell-cycle regu-
lators, such as CDKs, CYCLINs, pRB, and P53, frequently
resulted in dysfunctional cell-cycle progression and tumor-
igenesis (Cicatiello et al., 2004; Parija andDas, 2003; Yakov-
leva et al., 2004).
Although YY1 has multiple transcriptional regulation
functions in various biological processes, few reports have
examined the role of YY1 in pluripotency regulation. The
Orkin group has classified the ESC transcriptional network
into three distinct transcriptionmodules: the core module,
the PRCmodule, and theMycmodule (Kim et al., 2010). In
that regard, Vella et al. (2012) reported that YY1 did not
physically interact with PcG proteins, but extended the
MYC-related transcription factor network in embryonic
stem cells (ESCs). They found that YY1 binding had a
strong correlation with the components of the Myc mod-
ule, and YY1-regulated pluripotency through gene activa-
tion rather than repression, suggesting the involvement
of YY1 in Myc-related transcription network. However,
the in-depth mechanisms of YY1 in pluripotency regula-
tion, and its role in the core pluripotency network need
to be better defined. In the present study, we employed
immunoprecipitation (IP) for the affinity purification of
YY1 protein complexes in mouse ESCs (mESCs) in combi-
nation with mass spectrometry (MS) to construct an YY1Figure 1. YY1 Participates in OCT4-Mediated Pluripotency Regula
(A) CoIP assay shows the interaction between YY1 and the endogeno
(B) Heatmap depicting a significant correlation of gene expression alte
p < 0.05 was considered as significant.
(C) Scheme shows the biotin-dependent IP-MS system for identifying
(D) Western blotting for the expression of YY1 proteins. Lanes 3–10 rep
express both exogenous Flag-biotin-YY1 protein and endogenous YY1
as a negative control. They only express endogenous YY1 protein. b-
(E–G) Bar plots of molecular pathways enriched in (E) GO, (F) Mouse G
(KEGG) pathways analysis for 56 genes encoding proteins identified as
Displayed on the x axis are enrichment scores as calculated by –log(
passage 16, while ES bruce4 p13 means the bruce4 ESC line at passag
(H and I) Heatmaps showing the dynamic expressions of genes encod
during (H) EB differentiation and (I) early embryo development.
1326 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018interactome. We report the discovery of the BAF complex
as a bona fide YY1 partner. Mechanistically, the BAF com-
plex associates with YY1 to activate transcription, promote
ESC proliferation, and maintain pluripotency. In the pres-
ence of the BAF complex, YY1 participates in the core
pluripotent network to regulate ESC pluripotency.RESULTS
YY1 Is an Interacting Partner of OCT4 in mESCs
OCT4 is a well-known key pluripotency factor that is crit-
ical for stem cell pluripotency and somatic cell reprogram-
ming (Niwa et al., 2000; Scholer et al., 1990; Takahashi and
Yamanaka, 2006). The pluripotency protein interaction
network in ESCs has been identified, and this tight protein
network seems to function as a cellular module dedicated
to pluripotency (Wang et al., 2006). Although the interac-
tion of YY1 with the pluripotency module has been
mentioned by Wang et al. (2006), YY1 was not found to
be present in the OCT4-centered network in previous
studies (Pardo et al., 2010; van den Berg et al., 2010). Never-
theless, in the work by Pardo et al. (2010), YY1 was identi-
fied in one purification of OCT4 complex, but it was not
included in the final dataset because of the strict criteria
of result reproducibility. Importantly, we observed a phys-
ical interaction between YY1 andOCT4 by co-immunopre-
cipitation, (coIP) in J1 ESCs (Figure 1A). To further inspect
the functional interaction between YY1 and OCT4, we ex-
tracted the previously published knockdown dataset of
Oct4 or Yy1 by small hairpin RNAs (shRNAs) in mESCs
(Loh et al., 2006; Vella et al., 2012). We found that, among
the 292 genes with significant expression changes in
response to knockdown of Yy1, 42 were also significantly
affected by knockdown of Oct4 (Table S1). Furthermore,
among these 42 genes, 29 had a similar expression alter-
ation trend, with 11 genes (p = 0.014) downregulated
and the other 18 genes (p = 3.48 3 105) upregulatedtion
us OCT4 in J1 mESCs.
ration in response to knockdown of Yy1 or Oct4. The correlation with
of YY1 interactome.
resent the 8 cell clones transfected with Flag-biotin-Yy1. These cells
protein. BirA cells without transfection of Flag-biotin-Yy1 were used
Actin was used as a loading control.
ene Atlas (MGA), and (G) Kyoto Encyclopedia of Genes and Genomes
YY1-interacting proteins in (C). These genes are listed in Table S2.
p value). For MGA analysis, ES v26 p16 means the v26 ESC line at
e 13.
ing proteins identified as YY1, OCT4, and SOX2 interacting proteins
(legend on next page)
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(Figure 1B). These results indicate a close correlation be-
tween Yy1 and Oct4 in regulating gene expression and sug-
gest functional and cooperative roles for YY1 and OCT4 in
mESCs.
Generation of the YY1 Interactome in mESCs
To investigate the proteins interacting with YY1, we used
the YY1B3-ESC line expressing biotinylated YY1. Overex-
pression of Yy1 in YY1B3-ESC line versus BirA-ESC line
(control ESC line) was validated by qPCR (Figure S1A),
and the expressions of endogenous and exogenous
biotin-tagged YY1 were further confirmed by western blot
(Figure 1D). Similar to the R1 and BirA-ESC lines, the
YY1B3-ESC line displayed dome-shaped morphology
(Figure S1B), expressed wild-type levels of OCT4 and
NANOG (Figure S1C), and exhibited normal ESC clonoge-
nicity (Figures S1D and S1E). These results demonstrated
that overexpression of Yy1 did not change ESC identity.
We thus pulled down YY1 protein complexes in this
line using streptavidin beads, followed by MS analysis
(Figure 1C).
A total of 56 interacting proteins identified by MS anal-
ysis were significantly enriched in the biotinylated YY1 pu-
rification comparedwith controls (Table S2). It is important
to point out that, although we did uncover OCT4 in the
purification (with three peptide sequence both in YY1B3
and BirA cells; Table S2), it was not included in the final
candidate list because of our stringent selection criteria.
Interestingly, we found 7 components of the BAF complex,
11 components of the INO80 chromatin-remodeling
complex, and 4 components of the replication factor C
complex (Table S3), which functionally participates in
DNA topological changes, chromosomal remodeling, and
organization. We also found that YY1 interacted with
WDR5, HDAC2, CHD4, and RBBP5, which belong to
complexes involved in transcriptional regulation and cell-
cycle control (Table S3). These observations demonstratedFigure 2. YY1 Is Integrated into the Pluripotency Network throug
(A) ESCAPE analysis shows the OCT4 and TCFCP2L1 interactomes are s
list. The color indicates the experiment type, and the brightness indi
annealing to try to arrange the lists from the ESCAPE database by their
of the colored squares representing the gene lists from the ESCAPE dat
overlap with the input list. The results are also available in a table w
(B) Diagram depicting the proteins detected by interactome analysis.
yellow, the co-interacting proteins by all these three key transcripti
proteins are in blue.
(C) List of the co-interacting proteins of the three key transcription fa
represents the interaction reliability with YY1 in YY1B3 versus BirA ce
(left of the brackets) is more than 2-fold of that in BirA cells (in the bra
was considered to be significant.
(D) The composition of the BAF complex. YY1-interacting component
layer are co-interacted with YY1, OCT4, and TCFCP2L1. The three red
1328 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018that YY1 might participate in various biological processes
in mESCs.
Gene ontology (GO) analysis of biological processes
showed an enrichment in the regulation of chromatin
architecture and epigenetic modification categories (Fig-
ure 1E). TheMouse Gene Atlas analysis showed that the en-
coding genes of YY1-associated proteins have higher
expression levels in ESC lines (Figure 1F). In addition, the
Kyoto Encyclopedia of Genes and Genomes cellular
pathway analysis demonstrated an enrichment of proteins
involved in adherent junctions and cell cycle (Figure 1G).
Regulation of adherent junctions in ESCs is important to
form compact dome-shaped colonies (Stankovich et al.,
2011), while cell cycle is necessary for normal self-renewal,
proliferation, and division in ESCs (Re et al., 2014).
The YY1 Interactome Is Enriched for Proteins with
Critical Roles in mESC Maintenance
We analyzed the expression levels of the genes encoding
the YY1-interacting proteins in embryoid body (EB) differ-
entiation, early embryonic development, and somatic cell
reprogramming using previous published data (Hailesel-
lasse Sene et al., 2007; Heng et al., 2010; Tang et al.,
2011). First, the majority of the coding genes for YY1-asso-
ciated proteins (more than 75%) were highly expressed in
ESCs and downregulated during EB differentiation (Fig-
ure 1H). Second, single-cell transcriptomic analysis of early
mouse embryos (Tang et al., 2011) revealed that a large
number of the coding genes for YY1-associated proteins
(more than 80%) were upregulated during embryonic
development from oocyte to inner cell mass and estab-
lished ESCs (Figure 1I). These expression characteristics of
YY1 interactome are very similar with the characteristics
ofOCT4 and SOX2 interactomes (Figures 1H and 1I). Third,
the encoding genes of the YY1 and OCT4 interactomes ex-
hibited similar expression characteristics during reprog-
ramming, in which half of the genes were upregulatedh Interacting with the BAF Complex
ignificant similar to the YY1 interactome. Each square represents a
cates the level of local similarity among the lists. We use simulated
gene content similarity. The enriched terms appear as circles on top
abase on the canvas: the brighter the circle the more significant the
ith the associated p values on the right.
The three key transcription factors, YY1, OCT4, and TCFCP2L1, are in
on factors are in pink, the BAF complex subunits are in red, other
ctors YY1, OCT4, and TCFCP2L1. The peptide count of the 11 proteins
lls. If the peptide counts of YY1-interacting protein in YY1B3 cells
ckets), and simultaneously more than BirA plus two, the interaction
s are in red, others are in blue. The four red components in the top
components in the second layer are interacted with YY1 alone.
BA
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while others were downregulated (Figure S2A). GO analysis
showed the different functions between the up- and down-
regulated genes during reprogramming (Figures S2B and
S2C). These results suggest that the encoding genes of
YY1 interactome have relative higher expressions in plurip-
otent cells, but were downregulated when pluripotency
was abolished.
The BAF Complex Is Present in the YY1-Mediated
Pluripotency Regulatory Network
A high correlation among the interactomes of YY1, OCT4,
and TCFCP2L1 was observed by ESCAPE analysis (Fig-
ure 2A). LikeOCT4, TCFCP2L1 is also a pluripotency factor,
which stimulates ESC proliferation and self-renewal (Chen
et al., 2008; Ivanova et al., 2006). By comparing the previ-
ous published OCT4 and TCFCP2L1 interactomes (Ding
et al., 2012; van den Berg et al., 2010) with YY1 interactome
in this study, we identified 11 co-associated proteins of the
3 factors (Figure 2B). Interestingly, 4 of the 11 co-interact-
ing proteins belonged to the BAF complex (Figure 2C).
Given that another three components of the BAF complex
(ACTB, ACTL6B, and ACTG1) were found exclusively in
the YY1 interactome, YY1 totally interacted with seven
subunits of the BAF complex in mESCs (Figure 2D). These
results suggest a strong interaction between the BAF com-
plex and YY1 in mESC.
YY1 Interacts with the BAF Complex to PromotemESC
Proliferation
SMARCA4, also known as BRG1, is a core component of the
BAF complex. It plays an important role in maintaining
pluripotency by upregulating the expression of Oct4 and
other pluripotency genes (Singhal et al., 2014). We in-
spected the overlap of DNA binding sites between YY1Figure 3. YY1 Interacts with the BAF Complex to Promote Cell Pr
(A–D) Overlapping of two groups of genes whose promoters (±3 kb surr
respectively. YY1-SMARCA4 co-occupied genes are the 1,473 genes with
6,036 genes with promoters targeted only by YY1 but not by SMARCA4
YY1-only genes and YY1-SMARCA4 co-occupied genes. Bar plots of mole
analysis for YY1-SMARCA4 co-occupied genes. Displayed on the x axis
(E) Knockdown efficiency of Oct4, Yy1, or Smarca4 in mESCs was vali
pendent replicates. *p < 0.05 compared with control cells.
(F) Cell proliferation was evaluated by cell counting kit 8 cell viability
mESCs growth. The experiments were performed three times in tripl
replicate experiments.
(G) Knockdown of Oct4, Yy1, or Smarca4 significantly suppressed colo
independent replicate experiments. **p < 0.01 compared with contro
(H) Knockdown efficiency of mESCs treated with sh-Yy1, sh-Smarca4
dependent replicates and results shown as mean ± SD *p < 0.05 com
(I) Distribution of cell population in G1, S, and G2 phase. Cells were
triplicate. Blue, green, and red represent G1, S, and G2, respectively.
(J) Deficiency of Yy1, Smarca4, or double decreased S-phase cell popu
depicted as mean ± SD *p < 0.05, **p < 0.01 compared with control
1330 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018and SMARCA4, and identified 3,324 common sites (Fig-
ure S3A). The distribution analysis demonstrated that the
co-binding sites were associated preferentially with pro-
moter regions (about 44.2%), to a lesser extent with inter-
genic regions (about 36.5%), and only for the remaining
19% with gene body regions (Figure S3A). Nevertheless,
among the 18,408 YY1-only binding regions, 35.4%,
43.1%, and 21.5% were localized at promoter sites, inter-
genic regions, and gene bodies, respectively (Figure S3A).
We first analyzed the YY1 binding sites at promoter re-
gions. For the genes with their promoters only occupied
by YY1 and not SMARCA4 (YY1-only genes) (Figure 3A;
Table S4), functional analysis showed significant expres-
sion enrichment in ESC lines, with the roles mainly
focused on the regulation of RNA metabolism, amino
acid degradation, and Wnt signaling pathway (Figures
S3B–S3D). Definitely, 1,473 genes with promoters co-occu-
pied by both YY1 and SMARCA4were identified as co-occu-
pied genes (Figure 3A; Table S4). Like the YY1-only genes,
co-occupied genes also displayed significant expression
enrichment in ESC lines (Figure 3B). However, these genes
enriched for various biological processes, such as cell-cycle
progression (Figures 3C and 3D), which was quite different
from those of YY1-only genes. The outstanding functional
enrichment on cell cycle indicates the co-occupied genes
may regulate cell proliferation. To prove this hypothesis,
we knocked down Oct4, Yy1, or Smarca4 by shRNA, respec-
tively. The knockdown efficiency was measured by qPCR
(Figure 3E). Knockdown of Oct4, Yy1, or Smarca4 signifi-
cantly inhibited cell viability and colony formation (Fig-
ures 3F and 3G). Moreover, deficiency of either Yy1 or
Smarca4, or both (Figure 3H), significantly decreased
S-phase cell population but increased G1- or/and G2-phase
cell population (Figures 3I and 3J). Cell-cycle arrest isoliferation
ounding the TSS) were bound by YY1 (yellow) or SMARCA4 (orange),
promoters co-targeted by YY1 and SMARCA4. YY1-only genes are the
. YY1-all genes represent all the 7,509 YY1 bound genes comprising
cular pathways enriched in (B) MGA, (C) GO, and (D) KEGG pathways
are enrichment scores as calculated by –log(p value).
dated by qPCR. Data are presented as mean ± SD from three inde-
assay. Knockdown of Oct4, Yy1, or Smarca4 significantly inhibited
icate. Data are presented as means ± SD from three independent
ny formation of mESCs. Data are presented as mean ± SD from three
l cells.
, or double, respectively. Experiments were conducted in three in-
pared with control cells.
stained by DAPI. The experiments were performed three times in
lation but increased G1- or/and G2-phase cell population. Data are
cells.
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consistent with the decreased cell proliferation caused by
deficiency of Yy1 or Smarca4. These results demonstrated
that the interaction of YY1 and the BAF complex contrib-
uted to mESC proliferation.
YY1 Interacts with the BAF Complex to Maintain
Pluripotency
YY1 and SMARCA4 co-occupied genes were significant en-
riched for H3K4me3 (1,401 genes, 95.1%) while mildly en-
riched for H3K27me3 (305 genes, 20.7%), indicating that
YY1 and SMARCA4 may co-occupy promoters to activate
transcription in mESCs (Figure 4A). An enrichment com-
parison among all YY1-bound genes (YY1-all genes), YY1-
only genes and co-occupied genes with representative
histone markers revealed large enrichments of all the three
groups for H3K4me3. Interestingly, co-occupation by
SMARCA4 further elevated the H3K4me3 enrichment at
YY1 binding genes (Figure 4B). Within 29 pluripotency
genes (Ding et al., 2015) (Table S4), the promoters of 9 genes
were co-occupied by YY1 and SMARCA4 (Figure 4C). More-
over, knockdown of Yy1 significantly suppressed the
expression of several key pluripotent genes such as Oct4,
Nanog, and Sall4 (Figure 4D), supporting the fact that YY1
is important for maintenance of pluripotency.
We evaluated the influence of Oct4, Yy1, and Smarca4
deficiency on differentiation.Morphology analysis showed
that knockdown ofOct4,Yy1, or Smarca4 inmESCs resulted
in similarly smaller and irregular colonies compared with
control (Figure 4E). Knockdown of either Oct4, Yy1, or
Smarca4 did not influence the formation of EBs (Figure 4F).
As expected, since OCT4 inhibits neural ectoderm and tro-
phectoderm differentiation (Niwa et al., 2000; Thomson
et al., 2011), but promotes mesendoderm differentiation
in the presence of BMP4 (Wang et al., 2012), knockdown
of Oct4 suppressed the expression of Sox2 and Nanog, andFigure 4. YY1 Interacts with the BAF Complex to Promote Pluripo
(A) Overlapping of the YY1-SMARCA4 co-occupied genes (light red) w
2004), respectively.
(B) Histograms showing percentages of genomic regions in mESC prom
overlaps with H3K4me3 or H3K27Me3 peaks.
(C) The pluripotent genes with active histone marker H3K4me3 are b
(D) Knockdown of Yy1 decreased several pluripotency genes expressi
licates. *p < 0.05 compared with control cells.
(E) mESC morphology in response to deficiency of Oct4, Yy1, or Smarc
(F) The influence of Oct4, Yy1, or Smarca4 deficiency on the formatio
(G) The influence of Oct4, Yy1, or Smarca4 deficiency on the expressi
Results are shown as mean ± SD from three independent replicates. *
(H) Expression changes of Mex3b and Gtsf1 in response to knockdown
depicted as mean ± SD from three independent replicates. *p < 0.05 co
(I) Histograms showing percentages of the promoter targets of YY1 (YY
core, PRC or Myc transcription modules.
(J) Correlation map of binding loci showing the degree of co-occupan
well-defined three modules. Red indicates more frequent co-localizat
1332 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018the mesoderm markers Mixl1. Simultaneously, it signifi-
cantly induced the endoderm marker Sox17, the ectoderm
marker Pax3, and the trophectoderm marker Cdx2 (Fig-
ure 4G, top panel). Importantly, knockdown of Yy1 and
Smarca4 induced similar expression alterations of these
markers (Figure 4G, bottom panel). To further test the cor-
relation of YY1 and OCT4 in regulating gene expression,
we investigated whether the gene expression changes re-
sulting from either Oct4 or Yy1 knockdown would be simi-
larly rescued by the re-introduction of Smarca4. qRT-PCR
results showed that re-expression of Smarca4 rescued the
expression ofMex3b and Gtsf1 (Figure 4H). Taken together,
these results support that YY1 and SMARCA4 regulate plu-
ripotency, to some extent, in an OCT4-dependent manner.
YY1 Participates in the Core Pluripotency Regulation
Network through the BAF Complex
As described previously, the pluripotency transcriptional
network can be classified into three distinct modules
(Kim et al., 2010). We analyzed the enrichment of the
members in each module for YY1-all, YY1-only, and YY1-
SMARCA4 co-occupied genes, respectively. We observed
that the three modules were equivalently enriched for
YY1-all and YY1-only genes. However, very few genes in
the PRC module, but a large portion of genes in the core
module, were enriched for co-occupied genes (Figure 4I),
indicating that the BAF complex may draw YY1 into the
core pluripotency network. Furthermore, we collated
genome-wide targets for a global view of YY1 and YY1-
SMARCA4 co-bound regions along with transcription fac-
tors and histone marks (Das et al., 2014). The hierarchical
clustering tree and heatmap representation of occupancy
correlation revealed these three distinct ESC regulatory
modules (Figure 4J). Interestingly, YY1-all regions mainly
correlated with the PRC and Myc modules, whereastency
ith genes enriched for H3K27me3 (red) or H3K4me3 (Sato et al.,
oters where YY1 (YY1-all, YY1-only, or co-occupied with SMARCA4)
ound by YY1 and SMARCA4 simultaneously in mESCs.
on. Data are presented as mean ± SD from three independent rep-
a4, respectively.
n of embryoid bodies. Scale bar represents 100 mm.
on of the representative pluripotency and differentiation markers.
p < 0.05, **p < 0.01 compared with control cells.
of Oct4 or Yy1 were rescued by re-introduction of Smarca4. Data are
mpared with control cells. #p < 0.05 compared with knockdown cells.
1-all, YY1-only, or co-occupied with SMARCA4) overlapping with the
cy between each pair of the selected proteins representative of the
ion of each pair of proteins.
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Figure 5. YY1 Positively Regulates Super-Enhancer Activity in mESCs
(A) Average ChIP-seq read density for OSN around the YY1-SMARCA4 peaks’ center.
(B) YY1 and SMARCA4 bound regions are enriched for enhancers.
(C) Histograms showing percentages of genomic regions in mESCs where YY1 (all, only, or together with SMARCA4) and CTCF ChIP-seq peaks
overlap with H3K4me1 (K4me1), H3K27ac (K27ac), or both (K4me1 and K27ac) peaks.
(D) Heatmaps of YY1 binding loci sorted for the enhancer mark H3K4me1 and the active promoter mark H3K4me3. H3K27ac is an active
mark for both enhancers and promoters. mESC-specific enhancers are co-bound by OSN, MED1, and SMARCA4.
(E) Heatmap of YY1 and MED1 intensity at 231 mESC SEs. YY1 shares the majority of its targets with MED1.
(F) ChIP-seq density diagrams for MED1 and YY1 showing enrichment in SE regions.
(legend continued on next page)
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YY1-SMARCA4 co-bound regions segregated into the core
module (Figure 4J).
We evaluated the enrichment of OCT4 or c-MYC on YY1
targets. We observed that SMARCA4 co-occupancy
increased the OCT4 enrichment at YY1-bound regions
from 67.4% to 80.9% (Figure S3E). Moreover, we compared
the OCT4/YY1 co-target genes with the c-MYC/YY1 co-
bound genes. Two gene pools, the OCT4-only (6,749
genes) and the c-MYC-only (994 genes) were established
by analysis of chromatin immunoprecipitation sequencing
(ChIP-seq) data (Figure S3F). The overlapping rate of c-MYC
only genes with YY1-all genes was 51.7%, which is higher
than that of YY1-all genes with OCT4-only genes (39.3%)
(Figure S3G). Interestingly, in the presence of the BAF com-
plex, the overlapping rate of c-MYC only genes with YY1-
SMARCA4 co-occupied genes decreased to 10.6%, while
the overlapping rate of YY1-SMARCA4 co-occupied genes
with OCT4-only genes increased to 44.3% (Figure S3H),
supportive of YY1 participation into the OCT4-mediated
network via the BAF complex. Taken together, our observa-
tions indicate that transcriptional activation rather than
repression of genes in the core pluripotency network is
the main outcome of the interaction between YY1 and
the BAF complex in pluripotent stem cells.
YY1 Positively Regulates ESC-Specific Super-
Enhancers in mESCs
Active ESC enhancers are often co-occupied by multiple
core pluripotency factors, including OCT4, SOX2, and
NANOG (OSN) (Kagey et al., 2010; Whyte et al., 2013).
Interestingly, we found that YY1 and SMARCA4 co-bound
regions were enriched for OSN (Figure 5A), suggesting that
YY1 may interact with the BAF complex to positively regu-
late enhancer activity inmESCs.We selected the enhancers
based on their histone marks and if located farther than
3 kb from the transcription start site (TSS). We observed
that both YY1 and SMARCA4 were enriched at enhancer
regions in mESCs (Figure 5B). Importantly, YY1 and
SMARCA4 co-binding regions were greatly enriched for
H3K27ac and the combination of both marks (H3K4me1
and H3K27ac) (Figure 5C), suggesting a SMARCA4-depen-
dent function of YY1 in regulating ESC enhancer activity.
We sorted YY1 peaks by H3K4me1 and H3K4me3 to distin-
guish enhancers from promoters, and observed that both
enhancer and promoter regions enriched for YY1 were(G) Distribution of YY1 (Sato et al.), OCT4 (pink), MED1 (yellow), SMAR
density across a subset of mESC enhancers defined by MED1 ChIP-seq
dividing the ChIP-seq signals by the maximum signals individually, a
(H) ChIP-seq binding profiles for MED1, H3K27ac, YY1, OCT4, and SM
below the binding profiles. The SEs and scale bars are depicted below
(I) The mechanistic model of YY1 in regulating pluripotency in mES
promote pluripotent genes expression. OCT4 and TCFCP2L1 also partic
1334 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018co-bound by SMARCA4 and OSN (Figure 5D). Compared
with typical enhancers (TEs), ESC super-enhancers (SEs)
have a larger size and an increased capability to activate
transcription. They are enriched for MED1 and OSN in
ESCs (Whyte et al., 2013). In our study, we observed that
67.0% (14,571 out of 21,732) of YY1 binding peaks were
also occupied by MED1 (Figure 5E). Similarly, YY1 was
also enriched at SEs (Figure 5F). Moreover, YY1 had a signif-
icantly stronger enrichment density in SEs than TEs (Fig-
ures 5F–5H). Therefore, our results suggest a role of YY1
as a positive regulator of gene expression through regula-
tion of SEs inmESCs. Taken together, our data on the global
transcriptional cooperation between YY1 and the core
transcription network provide a regulatory mechanism
whereby YY1 targets both promoters and SEs to activate
the transcription of pluripotency genes (Figure 5I).
YY1 and the BAF Complex Regulate Different
Metabolic Pathways in mESCs and Lineage
Development
Lu et al. (2013) found an EZH2-independent function of
YY1, in which YY1 acts as an activator for many loci in
myoblasts. Consistent with Lu et al., we observed that
YY1 target genes were not enriched for either EZH2 or
H3K27me3 (only 3.3% and 5.9%, respectively) in mouse
myoblasts (Figure S4A). Instead, they were enriched for
H3K4me3 (more than 90%) (Figure S4B), indicating that,
in mouse myoblasts, YY1 functioned mostly as a transcrip-
tional activator similarly as in mESCs.
InmESCs, the genes targeted by YY1 partially overlapped
with those targeted by H3K27me3 (26.3%) (Figure 6A),
whereas they highly overlapped with those targeted by
H3K4me3 (93.7%) (Figure 6B). The YY1 targets were also
enriched by H3K4me3 in mouse myoblasts (Figure 6B).
Interestingly, the genes co-bound by YY1 and H3K4me3
inmyoblasts highly overlapped (88%)with those inmESCs
(Figure 6B), indicating that YY1 may play similar roles in
the two cell types via transcriptional activation. For these
genes co-bound by YY1 and H3K4me3 in both cell types,
GO analyses showed functional enrichments in RNA and
proteinmetabolism (Figure S4C). On the contrary, for these
genes specific to mESCs, the functional enrichments were
associated with DNA metabolism (Figure S4D). YY1 also
targeted certain genes in myotubes, but the amount
and functions were very limited (Figures 6B and S4E).CA4 (blue), and H3K27ac (Chudin et al., 2002) normalized ChIP-seq
signals. For each ChIP-seq data point, we normalized the plot by
nd we sorted them in an ascending order.
ARCA4 at the Mesdc1/2 locus in mESCs. Gene models are depicted
the binding profiles.
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Figure 6. YY1 Regulates Different Metabolic Pathways in mESCs and Lineage Development with the BAF Complex
(A) Overlapping of YY1 (yellow) and H3K27me3 (red) targets in mESCs.
(B) Venn diagrams shows the overlap between YY1 target genes (yellow) and H3K4me3 enrichment (Sato et al.) in mESCs (upper left) and
mouse myoblasts (upper middle). YY1 only targets few genes in mouse myotube (yellow, upper right). The bottom panel shows the overlap
between genes co-bound by YY1 and H3K4me3 in mESCs (light green) and in myoblasts (deep green).
(C) The list of metabolic genes with significant expression change in response to Yy1 knockdown in mESCs.
(D) ChIP-seq binding profiles for YY1 and SMARCA4 at the loci of representative genes for DNA, RNA, and protein metabolism in mESCs
(left). The TSS is marked in red at the beginning of each individual gene. The impact of Yy1 knockdown on gene expression is shown for
each ChIP-seq binding profile (right). The statistical significance was obtained by the t test. *p < 0.05, ***p < 0.001 compared with
control cells.
(E) Schematic diagram of the molecular mechanism of YY1-BAF complex in positive regulation of specific genes involving in maintenance
of pluripotency and cell fate decision in different cells.Knockdown of YY1 in mESCs resulted in notable expres-
sion changes of several genes involved in the DNA, RNA,
and protein metabolism (Figure 6C). These genes which
were co-bound by YY1 and SMARCA4 were downregulatedin response to Yy1 knockdown (Figure 6D). These results
demonstrate that YY1 cooperates with the BAF complex
to induce transcriptional activation of metabolic genes to
control pluripotency and cell fate in stem cells (Figure 6E).Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018 1335
Figure 7. The Function Model for YY1 in
the Absence or Presence of the BAF
Complex
Without the interaction with the BAF com-
plex, YY1 prefers to promote transcription
activation, and is involved in the PRC- or
MYC-related transcription factor network in
mESCs (upper panel). With the interaction
with the BAF complex, the transcriptional
activation function of YY1 is enhanced, and
the regulatory mode shifts to the core plu-
ripotency network (lower panel).DISCUSSION
Our study validated YY1 as an interacting partner of OCT4
for the regulation of pluripotency in mESCs, and identi-
fied the BAF complex among YY1 interactors. The BAF
complex has been shown to be not only essential for
maintenance of pluripotency, but also paramount in
enhancing the efficiency of somatic cell reprogramming
(Kadoch et al., 2013; Singhal et al., 2010). We demon-
strated that the BAF complex participated in the
YY1-mediated pluripotency regulation, promoted ESC
proliferation, and was necessary for YY1 to modulate its
activity in two ways (Figure 7). The first manner was to
enhance YY1-mediated transcription activation. Our data
strongly support that YY1 promotes transcription of the
pluripotency genes to maintain mESCs, largely through
the interaction with the BAF complex. ESCs are character-
ized by hyperdynamic and open chromatin, which is com-
pacted when these cells differentiate to multiple lineages
(Meshorer et al., 2006). To maintain the pluripotent state,
chromatin remodelers are required to prevent this chro-
matin compaction, therefore facilitating the expression
of pluripotency genes. Evidence showed that chromatin
remodelers, such as the BAF and INO80 complexes, are
crucial for the reversal of development and the reactiva-
tion of pluripotency genes such as Oct4 and Nanog, which
occurs during the nuclear reprogramming of a somatic cell
back into an ES-like cell state (Ho and Crabtree, 2010).
Importantly, we found YY1 interacted with many compo-
nents of the BAF and INO80 complex, indicating chro-
matin remodeling played key role in YY1-mediated
transcriptional activation.1336 Stem Cell Reports j Vol. 10 j 1324–1339 j April 10, 2018Here we proposed a second role for the BAF complex,
which is to anchor YY1 into OCT4-mediated core pluripo-
tency network. Although a recent paper reported that YY1
participated in the MYC-related transcriptional network in
regulating pluripotency (Vella et al., 2012), these findings
are not incompatible with our observations since our study
takes into consideration the presence of the BAF complex
in regulating YY1’s function. By associating with the BAF
complex, YY1 preferentially formed transcriptional activa-
tion complexes with OCT4 to bind gene promoters, en-
hancers, and, in particular, SEs. This role of YY1 would
further induce the expression of core pluripotency genes
including Oct4, Nanog, and Sall4, thereby forming a posi-
tive regulatory loop in the core pluripotent network.
Further, we provided multiple lines of evidence, which
integrate YY1 into the core pluripotency network rather
than the MYC- or PRC-related network. First, we identified
a direct interaction between YY1 and OCT4 by coIP assays,
and our interactome analysis showed a noticeable correla-
tion between YY1 and OCT4 interactomes. Second, mESCs
express a complex called esBAF, which is mainly character-
ized by containing the BAF subunit SMARCA4 rather than
BRM (Ho et al., 2009a). This complex regulates the core plu-
ripotency transcriptional network in mESCs (Ho et al.,
2009b). Third, the promoter and SE regions co-occupied
by YY1 and the BAF complex were also enriched for
OCT4 and H3K4me3, indicating an OCT4-dependent tran-
scriptional activation function of YY1 in mESCs. Last, by
collating YY1 and SMARCA4 co-transcriptome with the
three pluripotency modules, we found a relative higher
overlap of the YY1/SMARCA4 co-transcriptome with the
core module. Taken together, we conclude that YY1 is
integrated into the core network for pluripotency regula-
tion through the BAF complex.
In summary, our study provides strong evidence that YY1
is integrated into the core pluripotency network through
the BAF complex. YY1 occupies the promoter and SE re-
gions of its target genes and initiates their transcription.
YY1 regulates DNA, RNA, and protein metabolic processes
in stem cells together with the participation of the BAF
complex.EXPERIMENTAL PROCEDURES
Cell Line Generation, Manipulation, and Culture
All mouse ESC lines, including J1, R1, ZHBTc4, BirA, and YY1B3,
were cultured in the definedmedium as described in Supplemental
Experimental Procedures.
coIP and Western Blot Analysis
Nuclear extracts were prepared from J1mESCs. Endogenous OCT4
was immunoprecipitated with 5 mg of OCT4 antibody (Santa Cruz,
sc5279) pre-bound to ProteinG agarose beads (RocheDiagnostics),
and co-immunoprecipitated YY1 was identified by western blot
with a YY1 antibody (Santa Cruz, sc281). TUBULIN (Abcam,
ab6046) and b-ACTIN (Sigma, A5441)were used as loading control.
Nuclear Extraction, Affinity Purification, and MS
Analysis
We employed a YY1 transgene with a Flag-biotin dual tag for the
affinity purification of YY1 protein complexes using our well-
established protocols (Faiola et al., 2014). Detailed procedures are
provided in Supplemental Experimental Procedures.
Vector Construction
The shRNAs used in this study to knockdownOct4, Yy1, or Smarca4
are plko-puro-shOct4, plko-BSD-shYy1, and plko-BSD-shSmarca4. The
detailed information for vector construction is described in Sup-
plemental Experimental Procedures.
RNA Extraction and Real-Time qPCR
Total RNA was extracted from cell pellets using RNAzol reagent
(MRC, Cincinnati, OH, USA). Detailed procedures are provided
in Supplemental Experimental Procedures. The primers are listed
in Table S5.
Cell-Viability Assay
The cell counting kit 8 (Dojindo, Japan) was used for the determi-
nation of the number of viable cells. Detailed procedures are pro-
vided in Supplemental Experimental Procedures.
Colony-Formation Assay
On the fourth day after infection by shRNA lentivirus, 1,000 R1
mESCs with knockdown of Oct4, Yy1, or Smarca4 were seeded
into individual wells of a 6-well plate. After a 5-day culture, the
cell colonies were stained for alkaline phosphate. Experiments
were performed three times in triplicates.Cell-Cycle Analysis
Yy1-, Smarca4-, and double-deficient R1 mESCs were used for cell-
cycle analysis. Detailed procedures are provided in Supplemental
Experimental Procedures.Binding Site Analysis
As input for binding site analysis, previously published raw ChIP-
seq datasets were used, and the corresponding GSE numbers are
summarized in Table S6. Detailed analysis procedures are provided
in Supplemental Experimental Procedures. The called peaks and
their annotations are listed in Table S7.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and seven tables and can be found
with this article online at https://doi.org/10.1016/j.stemcr.2018.
02.004.
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